PixarBio Corporation (PXRB) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में चक्रीय उपभोग क्षेत्र, संचालन करती है Personal Products & Services उद्योग. वर्तमान CEO हैं Francis M. Reynolds.
PXRB के पास है IPO तिथि 2023-06-27, 30 पूर्णकालिक कर्मचारी, पर सूचीबद्ध Other OTC, बाजार पूंजीकरण $82.00.
PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company was founded in 2014 and is based in Medford, Massachusetts.
